Title : Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells.

Pub. Date : 2021 Feb

PMID : 33517269






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Sorafenib increased uPA secretion, which was abrogated by an Akt inhibitor. Sorafenib AKT serine/threonine kinase 1 Homo sapiens